No Data
NLS Pharmaceutics Unveils Promising Narcolepsy Treatment
NLS Pharmaceutics Announces Strategic Capital Restructuring
What's Going On With NLS Pharmaceutics Shares Monday?
Why Yum China Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
NLS Pharmaceutics NLSP Merger; Disc Medicine IRON Trial Design
NLS Pharmaceutics Enters Definitive Merger Agreement With Kadimastem; At Closing, NLS Will Issue Shares Of Its Common Stock To Kadimastem's Shareholders Based On An Initial Target Fully Diluted Share Split, Post Transaction, Of 85% To Kadimastem...
No Data
No Data